Datopotamab Deruxtecan (Dato-Dxd; Ds-1062), A Trop2 Adc, In Patients With Advanced Nsclc: Updated Results Of Tropion-Pantumor01 Phase 1 Study

ANNALS OF ONCOLOGY(2021)

引用 24|浏览10
暂无评分
关键词
NSCLC, antibody drug conjugate, TROP2
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要